Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cytokinetics Inc (CYTK)  
$53.90 0.38 (0.71%) as of 4:30 Mon 6/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 122,563,000
Market Cap: 6.61(B)
Last Volume: 8,264,325 Avg Vol: 8,242,049
52 Week Range: $26.88 - $108.06
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cytokinetics is a biopharmaceutical company focused on discovering, developing and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. Co.'s clinical-stage drug candidates are: Omecamtiv mecarbil, which is being evaluated for the potential treatment of heart failure; Reldesemtiv, which is being evaluated for treatment in patients with amyotrophic lateral sclerosis; Aficamten, which is an oral, small molecule cardiac myosin inhibitor being evaluated in patients with symptomatic, obstructive hypertrophic cardiomyopathy; and CK-3772271, its second cardiac myosin inhibitor.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 138,093 288,980 461,958 926,280
Total Sell Value $8,135,395 $19,867,810 $25,677,895 $46,442,456
Total People Sold 7 8 8 12
Total Sell Transactions 11 21 41 87
End Date 2024-03-24 2023-12-22 2023-06-23 2022-06-23

   
Records found: 1115
  Page 39 of 45  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Morgans David J Jr SVP-Drug Discovery and Dev   •       –      –    2006-12-15 4 OE $1.20 $6,000 D/D 5,000 50,000     -
   Trautman Jay K VP, Research   •       –      –    2006-12-11 4 AS $7.30 $7,300 D/D (1,000) 23,971     -
   Sabry James H CEO   •       •      –    2006-12-01 4 AS $7.18 $51,329 D/D (7,000) 0     -
   Sabry James H CEO   •       •      –    2006-12-01 4 OE $0.58 $6,903 D/D 7,000 6,963     -
   Blum Robert I President   •       –      –    2006-11-30 4 AS $7.29 $36,469 D/D (5,000) 65,000     -
   Blum Robert I President   •       –      –    2006-11-30 4 OE $0.58 $2,900 D/D 5,000 70,000     -
   Spudich James A Director   –       •      –    2006-11-21 4 AS $7.72 $17,001 D/D (2,200) 218,000     -
   Blum Robert I President   •       –      –    2006-11-15 4 AS $7.62 $38,094 D/D (5,000) 65,000     -
   Blum Robert I President   •       –      –    2006-11-15 4 OE $0.58 $2,900 D/D 5,000 70,000     -
   Morgans David J Jr SVP-Drug Discovery and Dev   •       –      –    2006-11-15 4 AS $7.80 $39,000 D/D (5,000) 45,000     -
   Morgans David J Jr SVP-Drug Discovery and Dev   •       –      –    2006-11-15 4 OE $1.20 $6,000 D/D 5,000 50,000     -
   Trautman Jay K VP, Research   •       –      –    2006-11-10 4 AS $7.29 $7,290 D/D (1,000) 24,971     -
   Sabry James H CEO   •       •      –    2006-11-01 4 AS $7.30 $51,100 D/D (7,000) 0     -
   Sabry James H CEO   •       •      –    2006-11-01 4 OE $0.58 $4,060 D/D 7,000 7,000     -
   Blum Robert I President   •       –      –    2006-10-30 4 AS $7.01 $35,075 D/D (5,000) 65,000     -
   Blum Robert I President   •       –      –    2006-10-30 4 OE $0.58 $2,900 D/D 5,000 70,000     -
   Spudich James A Director   –       •      –    2006-10-24 4 AS $6.99 $15,431 D/D (2,200) 220,200     -
   Trautman Jay K VP, Research   •       –      –    2006-10-19 4 AS $7.00 $7,000 D/D (1,000) 25,054     -
   Blum Robert I President   •       –      –    2006-10-16 4 AS $6.69 $33,748 D/D (5,000) 65,000     -
   Blum Robert I President   •       –      –    2006-10-16 4 OE $0.58 $2,900 D/D 5,000 70,000     -
   Morgans David J Jr SVP-Drug Discovery and Dev   •       –      –    2006-10-13 4 AS $6.67 $33,350 D/D (5,000) 45,000     -
   Morgans David J Jr SVP-Drug Discovery and Dev   •       –      –    2006-10-13 4 OE $1.20 $6,000 D/D 5,000 50,000     -
   Sabry James H President and CEO   •       •      –    2006-10-02 4 AS $6.40 $45,042 D/D (7,000) 0     -
   Sabry James H President and CEO   •       •      –    2006-10-02 4 OE $0.58 $4,060 D/D 7,000 7,000     -
   Blum Robert I President   •       –      –    2006-10-02 4 AS $6.36 $31,885 D/D (5,000) 65,000     -
  1115 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 39 of 45
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us